🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This research study is testing whether a weekly medication called tirzepati...
Status
Recruiting
Location
Institut de Recherches Cliniques de Montréal
Start Date
2026-05-19
Trial ID
NCT07284511
Obesity is one of the characteristics of type 2 diabetes mellitus. Most of ...
Status
Unknown
Location
Multiple Locations
Start Date
2015-05
Trial ID
NCT02503943
Treatments Being Tested
We are doing this study to learn more about how tirzepatide may help fight ...
Status
Active Not Recruiting
Location
Valley Clinical Trials, Inc.
Start Date
2023-02-08
Trial ID
NCT05536804
Treatments Being Tested
This study is for people who have multiple sclerosis, acute leukemia (in re...
Status
Suspended
Location
University of Chicago Medicine Comprehensive Cancer Center
Start Date
2024-01-26
Trial ID
NCT06171152
Treatments Being Tested
Cirrhosis is a form of advanced liver disease that can lead to serious comp...
Status
Recruiting
Location
Cleveland Clinic Main Campus
Start Date
2025-12-17
Trial ID
NCT07058155
The trial is a single-centre, randomized, double-blind, parallel trial in G...
Status
Completed
Location
Profil Institut für Stoffwechselforschung GmbH
Start Date
2016-01
Trial ID
NCT02660008
Liraglutide is a glucose-like peptide 1 agonist, currently used as an effec...
Status
Unknown
Location
Multiple Locations
Start Date
2020-04-01
Trial ID
NCT04008290
Treatments Being Tested
The main purpose of this study is to assess the safety and tolerability of ...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2013-06
Trial ID
NCT01870297
Treatments Being Tested
This trial is conducted in Europe. The aim of this trial is to test for bio...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2004-05-28
Trial ID
NCT01508897
Treatments Being Tested
The primary objective is to evaluate the safety and tolerability of VRB-103...
Status
Recruiting
Location
Nucleus Network
Start Date
2026-07-06
Trial ID
NCT07628127